Article Text

PDF
Effectiveness of computer-aided diagnosis (CADx) of breast pathology using immunohistochemistry results of core needle biopsy samples for synaptophysin, oestrogen receptor and CK14/p63 for classification of epithelial proliferative lesions of the breast
  1. Ichiro Maeda1,
  2. Manabu Kubota1,
  3. Jiro Ohta2,
  4. Kimika Shinno2,
  5. Shinya Tajima1,
  6. Yasushi Ariizumi1,
  7. Masatomo Doi1,
  8. Yoshiyasu Oana3,
  9. Yoshihide Kanemaki4,
  10. Koichiro Tsugawa5,
  11. Takahiko Ueno6,
  12. Masayuki Takagi1
  1. 1 Department of Pathology, St. Marianna University School of Medicine, Kawasaki, Japan
  2. 2 1st Development Department, 1st Business Development Unit, 3rd Division, Advanced Business Center, Dai Nippon Printing Co., Ltd, Tokyo, Japan
  3. 3 Department of Clinical Pathology, St. Marianna University Hospital, Kawasaki, Japan
  4. 4 Department of Radiology, St. Marianna University School of Medicine, Kawasaki, Japan
  5. 5 Department of Breast and Endocrine Surgery, St. Marianna University School of Medicine, Kawasaki, Japan
  6. 6 Unit of Medical Statistics, Faculty of Medical Education and Culture, St. Marianna University School of Medicine, Kawasaki, Japan
  1. Correspondence to Ichiro Maeda, Department of Pathology, St. Marianna University School of Medicine, Kawasaki 216-8511, Japan; ichirou{at}marianna-u.ac.jp

Abstract

Aims The aim of this study was to develop a computer-aided diagnosis (CADx) system for identifying breast pathology.

Methods Two sets of 100 consecutive core needle biopsy (CNB) specimens were collected for test and validation studies. All 200 CNB specimens were stained with antibodies targeting oestrogen receptor (ER), synaptophysin and CK14/p63. All stained slides were scanned in a whole-slide imaging system and photographed. The photographs were analysed using software to identify the proportions of tumour cells that were positive and negative for each marker. In the test study, the cut-off values for synaptophysin (negative and positive) and CK14/p63 (negative and positive) were decided using receiver operating characteristic (ROC) analysis. For ER analysis, samples were divided into groups with <10% positive or >10% positive cells and decided using receiver operating characteristic (ROC) analysis. Finally, these two groups categorised as ER-low, ER-intermediate (non-low and non-high) and ER-high groups. In the validation study, the second set of immunohistochemical slides were analysed using these cut-off values.

Results The cut-off values for synaptophysin, <10% ER positive, >10% ER positive and CK14/p63 were 0.14%, 2.17%, 77.93% and 18.66%, respectively. The positive predictive value for malignancy (PPV) was 100% for synaptophysin-positive/ER-high/(CK14/p63)-any or synaptophysin-positive/ER-low/(CK14/p63)-any. The PPV was 25% for synaptophysin-positive/ER-intermediate/(CK14/p63)-positive. For synaptophysin-negative/(CK14/p63)-negative, the PPVs for ER-low, ER-intermediate and ER-high were 100%, 80.0% and 95.8%, respectively. The PPV was 4.5% for synaptophysin-negative/ER-intermediate/(CK14/p63)-positive.

Conclusion The CADx system was able to analyse sufficient data for all types of epithelial proliferative lesions of the breast including invasive breast cancer. This system may be useful for pathological diagnosis of breast CNB in routine investigations.

  • BREAST
  • CANCER
  • COMPUTER ASSISTED
  • IMMUNOHISTOCHEMISTRY
  • KERATIN

Statistics from Altmetric.com

Footnotes

  • Contributors MK scanned in a whole-slide imaging and checked the imaging of all whole-slide imaging.

    JO and KS set parameter of image analysis software.

    ST, YA, MD, YO, YK, KT, and MT contributed to the planning and composition of this manuscript.

    TU analysed the statistics in this study.

  • Competing interests IM, MK, ST, YA, MD, YO and MT declare research funding from Dai Nippon Printing Co., Ltd to their institutions but with no direct payments to themselves. JO and KS are full-time employees of Dai Nippon Printing Co., Ltd. YK, KT and TU declare that they have no relevant conflicts of interest.

  • Ethics approval The study was approved by the ethics committee of St. Marianna University (approval number: 1915).

  • Provenance and peer review Not commissioned; internally peer reviewed.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.